Skip to main content

Advertisement

SpringerLink
Log in

A rare case of Opsoclonus-Myoclonus associated with SCLC

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

(Courtesy of dr. S. Coito)

References

  1. Oh S-SY, Kim J-S, Dieterich M et al (2019) Update on opsoclonus-myoclonus syndrome in adults. J Neurol 266:1541–1548

    Article  Google Scholar 

  2. Wong AM, Mussalam S, Tomlinson RD et al (2001) Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 189:71–81

    Article  CAS  Google Scholar 

  3. Armangué T, Sabater L, Torres-Vega E et al (2016) Clinical and immunological features of opsoclonus-myoclonus syndrome in the era of neuronal cell surface antibodies. JAMA Neurol 73(4):417–424

    Article  Google Scholar 

  4. Bataller L, GrausF SA et al (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus–myoclonus. Brain 124(2):437–443

    Article  CAS  Google Scholar 

  5. Horn L, Mansfield A, Mok T et al (2018) First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer (IMPOWER 133). N Engl J Med 379:2220–2229

    Article  CAS  Google Scholar 

  6. Paz-Ares L, Dvorkin M, Chen Y et al (2019) Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small–cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase 3 trial. Lancet 394(10212):1929–1939

    Article  CAS  Google Scholar 

  7. Graus F, Dalmau J (2019) Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol 16(9):535–548

    Article  CAS  Google Scholar 

  8. de Alarcon PA, Matthay KK, London WB et al (2018) Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc 2:25–34

    Article  Google Scholar 

  9. Rosenfeld M, Dalmau J (2013) Diagnosis and management of paraneoplastic neurologic disorders. Curr Treat Options Oncol 14:4

    Article  Google Scholar 

  10. Shams’ili S, de Beukelaar J, Gratama JW et al (2006) An uncontrolled trial of Rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253:16

    Article  Google Scholar 

  11. Pranzatelli MR, Tate ED, Travelstead AL et al (2006) Rituximab (anti-CD20) adjunctive therapy for opsoclonus–myoclonus syndrome. J Pediatr Hematol Oncol 28:585–593

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium

    M. Lebeer & J. Raskin

  2. Neurology and Stroke Unit Department, AZ Rivierenland, Rumst, Belgium

    M. Montagna

  3. Laboratoire Luxembourgeois d’analyses médicales, LLAM S.A., Luxembourg, Luxembourg

    S. Coito

  4. Department of Neurology, Antwerp University Hospital, Edegem, Belgium

    T. Reynders

Authors
  1. M. Lebeer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Montagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Coito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Reynders
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Raskin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Lebeer.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1. Video 1: Example of p-OMS in our patient (MP4 32638 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lebeer, M., Montagna, M., Coito, S. et al. A rare case of Opsoclonus-Myoclonus associated with SCLC. Acta Neurol Belg 120, 1017–1019 (2020). https://doi.org/10.1007/s13760-020-01402-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-020-01402-6

Search

Navigation